Instrument Inactif

Communiqués Biosante Pharmaceuticals Inc Nasdaq

Actions

US09065V3024

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

02/07	ANI Pharmaceuticals annonce l'approbation de la FDA et le lancement de Naproxen Delayed-Release Tablets, USP	CI
24/06	Les plus fortes hausses de la mi-journée	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP	02/07	AQ
ANI Pharmaceuticals to Acquire Alimera Sciences for $381 Million M&A Deal	27/06	AQ
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner	25/06	AQ
ANI Pharmaceuticals : to Discuss Acquisition of Alimera Sciences Presentation	24/06	PU
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences	24/06	AQ
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference	29/05	AQ
Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)	20/05	PR
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension	20/05	AQ
ANI PHARMACEUTICALS REPORTS RECORD FIRST QUARTER 2024 FINANCIAL RESULTS AND REITERATES 2024 GUIDANCE	13/05	AQ
ANI: Q1 Earnings Snapshot	10/05	AQ
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance	10/05	AQ
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences	01/05	AQ
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18/04	AQ
ANI Pharmaceuticals : Corporate Presentation - April 2024	17/04	PU
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09/04	AQ
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04/04	AQ
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03/04	AQ
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27/03	AQ
ANI Pharmaceuticals : Corporate Presentation - March 2024	12/03	PU
ANI: Q4 Earnings Snapshot	29/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Biosante Pharmaceuticals Inc Nasdaq

Actions

US09065V3024

Communiqués

Filtres